Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

Per Thor Straten; Mads Hald Andersen

doi:10.1016/j.vaccine.2011.03.007

Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

Center for Cancer Immune Therapy (CCIT), Department of Oncology, Copenhagen University Hospital , Herlev, Denmark.

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Vaccine
Vol/bind	29
Udgave nummer	21
Sider (fra-til)	3728
ISSN	0264-410X
DOI	https://doi.org/10.1016/j.vaccine.2011.03.007
Status	Udgivet - 12 maj 2011

Adgang til dokumentet

10.1016/j.vaccine.2011.03.007

Citationsformater

@article{bfac75d261f04b699fe0e34e7083b84d,

title = "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination",

keywords = "Dendritic Cells, Hepatitis B, Hepatitis B Vaccines, Hepatitis B virus, Humans, Immunity, Cellular, Indoleamine-Pyrrole 2,3,-Dioxygenase, T-Lymphocytes, Cytotoxic",

author = "Straten, \{Per Thor\} and Andersen, \{Mads Hald\}",

year = "2011",

month = may,

day = "12",

doi = "10.1016/j.vaccine.2011.03.007",

language = "English",

volume = "29",

pages = "3728",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "21",

}

TY - JOUR

T1 - Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

AU - Straten, Per Thor

AU - Andersen, Mads Hald

PY - 2011/5/12

Y1 - 2011/5/12

KW - Dendritic Cells

KW - Hepatitis B

KW - Hepatitis B Vaccines

KW - Hepatitis B virus

KW - Humans

KW - Immunity, Cellular

KW - Indoleamine-Pyrrole 2,3,-Dioxygenase

KW - T-Lymphocytes, Cytotoxic

U2 - 10.1016/j.vaccine.2011.03.007

DO - 10.1016/j.vaccine.2011.03.007

M3 - Journal article

C2 - 21420415

SN - 0264-410X

VL - 29

SP - 3728

JO - Vaccine

JF - Vaccine

IS - 21

ER -